This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wilson, J. R. Articles by Wiener, D. H. Search for Related Content PubMed PubMed Citation Articles by Wilson, J. R. Articles by Wiener, D. H.

Circulation, Vol 72, 72-81, Copyright © 1985 by American Heart Association

ARTICLES

Effect of the sympathetic nervous system on limb circulation and metabolism during exercise in patients with heart failure

JR Wilson, N Ferraro and DH Wiener

During exercise in patients with heart failure, activation of sympathetic vasoconstrictor nerves may impair vasodilation in active skeletal muscle and thereby interfere with skeletal muscle blood flow. To investigate this hypothesis, we examined the effect of acute alpha- adrenergic blockade with systemic administration of prazosin (10 patients) or regional administration of phentolamine (eight patients) on blood flow, vascular resistance, oxygen consumption (VO2), and lactate release in the leg during maximal bicycle exercise in patients with heart failure. During control exercise, systemic VO2 increased to 12.6 +/- 4.3 ml/min/kg (normal greater than 20 to 25 ml/min/kg), leg blood flow to 2.8 +/- 1.8 liters/min, and leg lactate release to 362 +/- 256 mg/min. Prazosin decreased systemic vascular resistance (12.5 +/- 3.2 to 9.7 +/- 2.5 units; p less than .003) and mean arterial pressure (101 +/- 20 to 87 +/- 22 mm Hg; p less than .002) at maximal exercise, supporting the presence of substantial sympathetic vasoconstrictor nerve activity. Prazosin also decreased leg resistance during exercise. However, the magnitude of leg blood flow, leg oxygen extraction, and leg VO2 during exercise were unchanged, suggesting that vasodilation in the leg was produced by an autoregulatory response to the drop in blood pressure rather than by blockade of sympathetic vasoconstriction. Maximal systemic VO2 and leg lactate release were also not improved. Regional blockade with phentolamine did not substantially drop the arterial blood pressure and had no effect on vasodilation, blood flow, VO2, and lactate release in the leg during exercise. These data suggest that during exercise in patients with heart failure, the sympathetic nervous system helps to sustain arterial blood pressure and that this beneficial effect is not associated with adverse effects on blood flow to working skeletal muscle.

This article has been cited by other articles:

				C. C. Lang, D. B. Chomsky, J. Butler, S. Kapoor, and J. R. Wilson Prostaglandin production contributes to exercise-induced vasodilation in heart failure J Appl Physiol, December 1, 1997; 83(6): 1933 - 1940. [Abstract] [Full Text] [PDF]

				C. C. Lang, G. H. Rayos, D. B. Chomsky, A. J. J. Wood, and J. R. Wilson Effect of Sympathoinhibition on Exercise Performance in Patients With Heart Failure Circulation, July 1, 1997; 96(1): 238 - 245. [Abstract] [Full Text]

				J. R. Wilson Exercise Intolerance in Heart Failure : Importance of Skeletal Muscle Circulation, January 15, 1995; 91(2): 559 - 561. [Full Text]

				J. Myers and V. F. Froelicher Hemodynamic Determinants of Exercise Capacity in Chronic Heart Failure Ann Intern Med, September 1, 1991; 115(5): 377 - 386. [Abstract] [PDF]